ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00095160
Recruitment Status : Completed
First Posted : November 2, 2004
Last Update Posted : November 29, 2017
Sponsor:
Collaborator:
Pfizer
Information provided by:
Masonic Cancer Center, University of Minnesota

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2006
  Actual Study Completion Date : January 2006